New blood test spots cancer DNA in eye melanoma patients
NCT ID NCT01334008
First seen Nov 25, 2025 · Last updated May 16, 2026 · Updated 12 times
Summary
This study aimed to develop and validate a blood test that can detect circulating tumor DNA in patients with metastatic choroidal melanoma, a rare eye cancer that has spread. Researchers collected blood samples from 40 adult patients and compared different detection techniques (PAP, BEAMing, NGS) to see which was most feasible, sensitive, and cost-effective. The goal was to improve monitoring of the disease without needing a tissue biopsy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOROIDAL MELANOMA, DIFFUSE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Curie
Paris, 75005, France
Conditions
Explore the condition pages connected to this study.